ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000031866
Date of registration:	23/03/2018
Prospective Registration:	Yes
Primary sponsor:	The Institute of Medical Science, The University of Tokyo
Public title:	An exploratory study to identify biomarkers of resistance to chemotherapy in multiple myeloma
Scientific title:	An exploratory study to identify biomarkers of resistance to chemotherapy in multiple myeloma - biomarker study in MM
Date of first enrolment:	2018/03/23
Target sample size:	20
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036386
Study type:	Observational
Study design:	Not selected Not selected
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Yoichi Imai
Address:	4-6-1 Shirokanedai, Minato-ku, Tokyo Japan
Telephone:	03-5449-8111
Email:	imaitky@ims.u-tokyo.ac.jp
Affiliation:	IMSUT hospital, The Institute of Medical Science, The University of Tokyo Department of Hematology/Oncology

Name:	Hiroshi Yasui
Address:	4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan
Telephone:	03-5449-8111
Email:	hiroyasu@ims.u-tokyo.ac.jp
Affiliation:	IMSUT hospital, The Institute of Medical Science, The University of Tokyo Department of Hematology/Oncology

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: Patients who are found to be inappropriate for this trial as judged by the principal investigator or the sub-investigator

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Multiple Myeloma

Intervention(s)

Primary Outcome(s)

genetic mutations in tumor DNA

Secondary Outcome(s)

genetic mutations in circulating cell-free DNA

Secondary ID(s)

Source(s) of Monetary Support

Celgene K.K.

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date: 26/02/2018
Contact:

dctsm@ims.u-tokyo.ac.jp

the 3rd Research Ethics Committee

03-5449-8111

dctsm@ims.u-tokyo.ac.jp

Results

Results available:	Yes
Date Posted:	08/08/2023
Date Completed:	31/03/2021
URL:	https://link.springer.com/article/10.1007/s10147-021-01991-z

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.